Convatec Group (CTEC)

Sector:

Health Care

Index:

FTSE 100

231.00p
   
  • Change Today:
    -2.40p
  • 52 Week High: 295.40
  • 52 Week Low: 213.40
  • Currency: UK Pounds
  • Shares Issued: 2,049.79m
  • Volume: 10,209,913
  • Market Cap: £4,735.01m
  • RiskGrade: 96
  • Beta: 0.02

CTEC Overview

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. Its products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. Based in Reading, it employs over 9,000 people in more than 100 countries.
Competitors: Consort Medical

Key Personnel

Chairman: John McAdam
CEO: Karim Bitar
CFO: Jonny Mason
Independent Non-Executive Director: Sharon O'Keefe
Independent Non-Executive Director: Constantin Coussios
Independent Non-Executive Director: Brian May
Independent Non-Executive Director: Kimberly Lody
Independent Non-Executive Director: Heather Mason
Senior Independent Non-Executive Director: Margaret Ewing
Non-Executive Dir:

Contact Details

Address: 7th Floor, 20 Eastbourne Terrace, London, United Kingdom, W2 6LG
Phone: +44 (0) 118 952 8100
Website: http://www.convatecgroup.com

Listings

Sector: Health Care(LSE)
Index: FTSE 100, FTSE 350, FTSE All-Share
ISIN: GB00BD3VFW73

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

CTEC Market Data

Currency UK Pounds
Share Price 231.00p
Change Today -2.40p
% Change -1.03 %
52 Week High 295.40
52 Week Low 213.40
Volume 10,209,913
Shares Issued 2,049.79m
Market Cap £4,735.01m
Beta 0.02
RiskGrade 96

CTEC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.4% below the market average94.4% below the market average94.4% below the market average94.4% below the market average94.4% below the market average
75.76% below the sector average75.76% below the sector average75.76% below the sector average75.76% below the sector average75.76% below the sector average
Price Trend
43.39% above the market average43.39% above the market average43.39% above the market average43.39% above the market average43.39% above the market average
82.86% above the sector average82.86% above the sector average82.86% above the sector average82.86% above the sector average82.86% above the sector average
Income
73.89% below the market average73.89% below the market average73.89% below the market average73.89% below the market average73.89% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
51.50% above the market average51.50% above the market average51.50% above the market average51.50% above the market average51.50% above the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average

What The Brokers Say

Strong Buy 7
Buy 8
Neutral 2
Sell 1
Strong Sell 0
Total 18
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CTEC Dividends

  Latest Previous
  Interim Final
Ex-Div 21-Aug-25 17-Apr-25
Paid 01-Oct-25 29-May-25
Amount 1.88¢ 4.59¢

Trades for 01-Aug-2025

Time Volume / Share Price
14:47 1 @ 228.80p
14:47 0 @ 228.80p
16:38 938,219 @ 230.70p
16:37 16,981 @ 231.00p
16:35 81,051 @ 231.00p

CTEC Key Personnel

CEO Karim Bitar
Chair John McAdam
CFO Jonny Mason

Top of Page